Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365922 · ClinicalTrials.gov registry record
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1,489
- Enrollment target
NCT02365922: Completed study, sponsored by University of California, San Francisco.
NCT02365922 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1,489 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02365922 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1,489 participants
- Enrollment target
Study Summary
Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative diseases that correspond to four main overlapping clinical syndromes: frontotemporal dementia (FTD), primary progressive aphasia (PPA), corticobasal degeneration syndrome (CBS) and progressive supranuclear palsy syndrome (PSPS). The goal of this study is to build a FTLD clinical research consortium to support the development of FTLD therapies for new clinical trials. The consortium, referred to as Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL), will be headquartered at UCSF and will partner with six patient advocacy groups to manage the consortium. Participants will be evaluated at 14 clinical sites throughout North America and a genetics core will genotype all individuals for FTLD associated genes.
Primary Outcome
Neuropsychological test scores from the Uniform Data Set FTLD Module will be collected and compared across patient populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,489 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-09 |
What the finished NCT02365922 record still lists
NCT02365922 is an observational study that tracks outcomes without assigning an intervention. Its 1,489 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02365922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02365922 about?
NCT02365922 is a clinical study titled "Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)". Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative diseases that correspond to four main overlapping clinical syndromes: frontotemporal dementia (FTD), primary progressive aphasia (PPA), corticobasal degeneration syndrome (CBS) and progr...
What is the current status of trial NCT02365922?
This trial is currently completed. The enrollment target is 1,489 participants. The study started on 2014-09. Estimated completion is 2020-09.
Who is sponsoring clinical trial NCT02365922?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia